Literature DB >> 2213157

Surgical treatment of thyrotropin-secreting pituitary adenomas.

I E McCutcheon1, B D Weintraub, E H Oldfield.   

Abstract

Thyrotropin-secreting pituitary adenomas have been diagnosed more frequently as radiographic techniques and biochemical assays have improved; however, they remain uncommon and are unfamiliar to most neurosurgeons. This report concerns eight patients with hyperthyroidism, inappropriately elevated levels of serum thyrotropin and alpha-subunit, and radiographic evidence of pituitary tumor. All underwent surgery and had pathological confirmation of a thyrotropin-secreting adenoma, and most had been subjected to prior ablation of the thyroid gland. Only one tumor was a microadenoma; the others ranged in size from 1.4 to 12 cm, and invasion of parasellar structures was common. Thyrotropin, triiodothyronine, thyroxine, and alpha-subunit were measured preoperatively and at intervals postoperatively. Coexistent hormonal abnormalities (which occurred in all patients) included acromegaly and hyperprolactinemia and were also monitored. All four patients who had tumors less than 2 cm in diameter remain alive. Complete extirpation of tumor in these patients produced rapid correction of all hormonal abnormalities and resolution of clinical hyperthyroidism. The other four patients had larger invasive tumors: two died soon after surgery, one died of disseminated tumor 8 years after presentation, and one remains alive with residual tumor. Tumors secreting thyroid-stimulating hormone are less easily cured by surgery than are other types of pituitary adenoma because of the large size and invasive features that many attain during the delay to diagnosis; medical therapy can subdue the tumor but not cure it. The experience with these patients establishes the importance of early diagnosis and surgical excision for successful treatment, and demonstrates the utility of modern diagnostic techniques for finding these lesions. As occurs in Nelson's syndrome after adrenalectomy for Cushing's disease, ablation of the target organ may allow the tumor to convert to a more clinically malignant form which is resistant to cure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213157     DOI: 10.3171/jns.1990.73.5.0674

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

1.  A rare case and a rapid tumor response to therapy: dramatic reduction in tumor size during octreotide treatment in a patient with TSH-secreting pituitary macroadenoma.

Authors:  Cihangir Erem; Arif Hacihasanoglu; Ahmet Sari; Halil Onder Ersöz; Kubilay Ukinç; Sami Fidan
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

2.  TSH-Secreting Pituitary Adenoma: Current Management and Review.

Authors:  M K Kole; J Goldman; J P Rock
Journal:  Skull Base Surg       Date:  1997

Review 3.  Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.

Authors:  Amy Yao; Priti Balchandani; Raj K Shrivastava
Journal:  World Neurosurg       Date:  2017-04-28       Impact factor: 2.104

4.  Surgical management of thyrotropin-secreting pituitary adenomas.

Authors:  M Losa; P Mortini; A Franzin; R Barzaghi; C Mandelli; M Giovanelli
Journal:  Pituitary       Date:  1999-08       Impact factor: 4.107

Review 5.  Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment.

Authors:  N Sanno; A Teramoto; R Y Osamura
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

6.  Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.

Authors:  P Iglesias; J J Díez
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

7.  Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma.

Authors:  N P Verhoeff; F J Bemelman; W M Wiersinga; E A van Royen
Journal:  Eur J Nucl Med       Date:  1993-06

8.  Effectiveness of long-acting octreotide in suppressing hormonogenesis and tumor growth in thyrotropin-secreting pituitary adenomas: report of two cases.

Authors:  L Gourgiotis; M C Skarulis; F Brucker-Davis; E H Oldfield; N J Sarlis
Journal:  Pituitary       Date:  2001-08       Impact factor: 4.107

9.  A Plurihormonal TSH-Secreting Pituitary Microadenoma: Report of a Case with an Atypical Clinical Presentation and Transient Response to Bromocriptine Therapy.

Authors:  Sergio Zuniga; Victoria Mendoza; Ignacio Felix Espinoza; Arturo Zarate; Macrina Mason; Moises Mercado
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

10.  Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy.

Authors:  Sumapa Chaiamnuay; Mark Moster; M Richard Katz; Young Nam Kim
Journal:  Pituitary       Date:  2003-09       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.